Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05481931
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
Sponsor: Evolus, Inc.
View on ClinicalTrials.gov
Summary
Non-interventional PASS of NUCEIVA for the treatment of moderate-to-severe glabellar lines to provide additional characterisation of the long-term safety of NUCEIVA in the real-world clinical practice setting.
Official title: Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
OBSERVATIONAL
Enrollment
756
Start Date
2023-03-15
Completion Date
2026-01
Last Updated
2025-08-05
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
prabotulinumtoxinA
Botulinum toxin Type A powder for solution for injection
Locations (1)
Cologne Dermatology
Cologne, Germany